These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17323463)

  • 1. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Shoelson SE
    J Appl Physiol (1985); 2007 Feb; 102(2):820; author reply 825. PubMed ID: 17323463
    [No Abstract]   [Full Text] [Related]  

  • 2. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Weigert C; Lehmann R; Schleicher ED
    J Appl Physiol (1985); 2007 Feb; 102(2):820-1; author reply 825. PubMed ID: 17323462
    [No Abstract]   [Full Text] [Related]  

  • 3. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Bülow J
    J Appl Physiol (1985); 2007 Feb; 102(2):822-3; author reply 825. PubMed ID: 17323467
    [No Abstract]   [Full Text] [Related]  

  • 4. Point:counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Spangenburg EE
    J Appl Physiol (1985); 2007 Feb; 102(2):820; author reply 825. PubMed ID: 17284658
    [No Abstract]   [Full Text] [Related]  

  • 5. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    McGuinness OP
    J Appl Physiol (1985); 2007 Feb; 102(2):823; author reply 825. PubMed ID: 17323468
    [No Abstract]   [Full Text] [Related]  

  • 6. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Plomgaard P; Fischer CP
    J Appl Physiol (1985); 2007 Feb; 102(2):822; author reply 825. PubMed ID: 17323466
    [No Abstract]   [Full Text] [Related]  

  • 7. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Bastard JP; Lagathu C; Caron M; Capeau J
    J Appl Physiol (1985); 2007 Feb; 102(2):821-2; author reply 825. PubMed ID: 17323465
    [No Abstract]   [Full Text] [Related]  

  • 8. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Jansson JO; Wallenius V
    J Appl Physiol (1985); 2007 Feb; 102(2):821; author reply 825. PubMed ID: 17323464
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis.
    Mooney RA
    J Appl Physiol (1985); 2007 Feb; 102(2):816-8; discussion 818-9. PubMed ID: 17284655
    [No Abstract]   [Full Text] [Related]  

  • 10. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.
    Pedersen BK; Febbraio MA
    J Appl Physiol (1985); 2007 Feb; 102(2):814-6. PubMed ID: 17068210
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of interleukin-6 signalling in glucose and lipid metabolism.
    Glund S; Krook A
    Acta Physiol (Oxf); 2008 Jan; 192(1):37-48. PubMed ID: 18171428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
    Wunderlich FT; Ströhle P; Könner AC; Gruber S; Tovar S; Brönneke HS; Juntti-Berggren L; Li LS; van Rooijen N; Libert C; Berggren PO; Brüning JC
    Cell Metab; 2010 Sep; 12(3):237-49. PubMed ID: 20816090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute administration of IL-6 improves indices of hepatic glucose and insulin homeostasis in lean and obese mice.
    Peppler WT; Townsend LK; Meers GM; Panasevich MR; MacPherson REK; Rector RS; Wright DC
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G166-G178. PubMed ID: 30383412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice.
    Benrick A; Wallenius V; Asterholm IW
    Exp Physiol; 2012 Nov; 97(11):1224-35. PubMed ID: 22523382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-term low-intensity exercise on insulin sensitivity, insulin secretion, and glucose and lipid metabolism in non-obese Japanese type 2 diabetic patients.
    Kishimoto H; Taniguchi A; Fukushima M; Sakai M; Tokuyama K; Oguma T; Nin K; Nagata I; Hayashi R; Kawano M; Hayashi K; Tsukamoto Y; Okumura T; Nagasaka S; Mizutani H; Nakai Y
    Horm Metab Res; 2002 Jan; 34(1):27-31. PubMed ID: 11832998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training and antioxidants: relief from oxidative stress and insulin resistance.
    Henriksen EJ; Saengsirisuwan V
    Exerc Sport Sci Rev; 2003 Apr; 31(2):79-84. PubMed ID: 12715971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New mechanisms by which physical exercise improves insulin resistance in the skeletal muscle].
    Pauli JR; Cintra DE; Souza CT; Ropelle ER
    Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):399-408. PubMed ID: 19649376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.
    Kaur A; Patankar JV; de Haan W; Ruddle P; Wijesekara N; Groen AK; Verchere CB; Singaraja RR; Hayden MR
    Diabetes; 2015 Apr; 64(4):1168-79. PubMed ID: 25338812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain GLP-1 and insulin sensitivity.
    Sandoval D; Sisley SR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():27-32. PubMed ID: 25724479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarity Protein AF6 Controls Hepatic Glucose Homeostasis and Insulin Sensitivity by Modulating IRS1/AKT Insulin Pathway in an SHP2-Dependent Manner.
    Dai C; Wang X; Wu Y; Xu Y; Zhuo S; Qi M; Ji W; Zhan L
    Diabetes; 2019 Aug; 68(8):1577-1590. PubMed ID: 31127058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.